EW

EDWARDS LIFESCIENCES CORPORATION

EW · CIK 1099800 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$6.1B
20182025
Net Income$1.1B
20182025
Operating CF$1.6B
20182025
Free Cash Flow$1.3B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$6.1B$1.4B$6.0B$5.4B$5.2B$1.2B$1.2B$1.0B
Cost of Revenue$1.3B$1.1B$1.4B$1.1B$1.2B$1.1B$1.1B$0.9B
Gross Profit$4.7B$1.1B$4.6B$4.3B$4.0B$0.9B$0.9B$0.7B
R&D Expense$1.1B$1.1B$1.1B$0.9B$0.9B$0.8B$0.8B$0.6B
SG&A Expense$2.1B$1.8B$1.8B$1.6B$1.5B$1.2B$1.2B$1.1B
Operating Income$1.3B$1.4B$1.5B$1.7B$1.7B$0.9B$1.1B$0.7B
Net Income$1.1B$0.4B$1.4B—————
EPS (Basic)$1.84$0.65$2.31$2.46$2.41$0.50$1.34$0.03
EPS (Diluted)$1.83$0.65$2.30$2.44$2.38$0.49$1.32$0.03

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$13.7B$13.1B$9.4B$8.3B$8.5B$7.2B$6.5B$5.3B
Current Assets$6.7B$6.3B$4.0B$3.1B$3.2B$3.1B$3.0B$2.3B
Cash & Equivalents$2.9B$3.0B$1.1B$0.8B$0.9B$1.2B$1.2B$0.7B
Total Liabilities$3.4B$3.0B$2.6B$2.5B$2.7B———
Current Liabilities$1.8B$1.5B$1.2B$1.0B$1.0B$0.9B$0.9B$0.9B
Stockholders' Equity$10.3B$10.0B$6.7B$5.8B$5.8B$4.6B$4.1B$3.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$1.6B$0.5B$0.9B$1.2B$1.7B$1.1B$1.2B$0.9B
Investing Cash Flow$-0.7B$2.3B$0.2B$0.3B$-1.7B$-0.5B$-0.6B$0.1B
Capital Expenditures$0.3B$0.3B$0.3B$0.2B$0.3B$0.4B$0.3B$0.2B
Financing Cash Flow$-1.0B$-1.0B$-0.7B$-1.6B$-0.4B$-0.5B$-0.1B$-1.1B
← Companies